Skip to content

Meghan E. Shea, M.D.

NPI 1063733236ActiveIndividual· Internal Medicine, Medical Oncology· Boston, MA

Internal Medicine, Medical Oncology (M.D.) in Boston, Massachusetts, trained at University of Massachusetts Medical School (class of 2010). Their prescriptions cost Medicare Part D more than their services did: $1,437,015 for 611 claims, against $58,935 paid for services in 2024. Genmab U.S., Inc. was the largest of 3 companies reporting payments in 2025, $9,439 in all, mostly consulting fees.

Overview

NPI1063733236
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 22, 2010
Last updated in NPPESJan 16, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202X251127MA
Internal Medicine207R00000XL-244125MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (MA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients154
Services billed918 across 15 procedure codes
Paid by Medicare$58,935

Part D prescriptions in 2024

Prescriptions (claims)611 · 842 30-day fills
Patients104
Total drug cost$1,437,015
Generic share76% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Massachusetts Medical School
Graduation year2010
Medicare specialtyHematology/Oncology
TelehealthOffers telehealth

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$9,439 · 21 payments from 3 companies
  • 2024$2,368 · 4 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Genmab U.S., Inc.$5,30511
Abbvie Inc.$4,0919
Astrazeneca Pharmaceuticals LP$43.251

What the 2025 payments were for

  • Consulting Fee$6,938 · 2 payments
  • Travel and Lodging$1,977 · 9 payments
  • Food and Beverage$481.27 · 9 payments
  • Education$43.25 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Medical Oncology providers in Boston

All Internal Medicine, Medical Oncology providers in Massachusetts →